I know of a company that's using dried blood for testing, which apparently is the same as what Theranos was saying from a layman's point of view.

The level of process you're talking about usually isn't in a deck; it's usually "get sample - mail it in - get results."

Decks are pitched to investors, who most of the time have more money than technical skills in the area in question.